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Radiofrequency ablation for hypertrophic
obstructive cardiomyopathy: A novel technique to
reduce left ventricular outflow tract gradient
A.B. Shelke, S.D. Yalagudri, D. Saggu, S. Goel, S. Nair,
C. Narasimhan
CARE hospitals, Hyderabad, India
Background: Alcohol septal ablation (ASA) is an acceptable alter-
native to surgical myectomy in patients with hypertrophic
obstructive cardiomyopathy (HOCM).However, the anatomical
variability of septal branch, risk of complete heart block (CHB)
limits its therapeutic use. Recently radiofrequency ablation (RFA)
of septum has shown reduction in gradient, although with
considerable risk of CHB.
Methods: Seven symptomatic HOCM patients (mean age 43.7±15.6
yrs, 5 men) with significant gradients on drug therapy were
studied. These patients were unwilling for surgery and had un-
favorable anatomy for ASA. Trans-aortic route was used to
approach the LV septum. Areas with left bundle branch, left HIS
signals, fascicular potentials were tagged using 3 D electro-
anatomical system (CARTO or NavX) to avoid RFA in these areas.
Ablation of left septum was performed using open irrigated tip
catheter in transition zone of pressure where maximum bulge of
LV septum was seen on intracardiac echocardiography. Patients
were followed up at 1, 6 and 12 months post procedure.
Results: Baseline mean LVOT gradient by Doppler echocardiog-
raphy was 81± 14.8 mm of Hg. Post procedure mean Doppler
echocardiography gradients were 48.5 ±22.6 mm of Hg (P value
-0.004), 49.8 ±19.3 mm of Hg (P value -0.004), 42.8 ±26.1 mm of Hg
(W¼2, significant at p 0.05) at 1, 6 and 12 months respectively.
Mean NYHA class improved from 3.0 to 1.5 ±0.7. One patient with
severe mitral regurgitation underwent surgical myectomy and
mitral valve replacement for persistent symptoms and high gra-
dients. One patient developed pulmonary edema immediate post
procedure. She was managed with invasive ventilation and I.V.
diuretics. No one developed peri or post procedure conduction
disturbances or other complications.
Conclusions: RFA in patients with HOCM causes sustained
reduction in the LVOT gradient and symptomatic improvement.
Technical difficulty in catheter manipulation and septal contact
may influence the outcome.
Effect of vitamin D supplementation with patients
with NYHA class 2 and 3
Somalaram Venkatesh, C.V. Harinarayan
Fortis Hospitals, Bangalore, India
Aim: To study the effect of vitamin D supplementation on ejection
fraction (EF) and six minute walk test (WT) in patients with New
York Heart Association (NYHA) class 2 and 3 failure patients.
Methods: Thirty subjects (M:F 19:11) (68.6+12 yrs) with NYHA class
2-3 were assessed for their history of diabetes, hypertension,
ischemic heart disease (IHD),drug intake, ejection fraction(EF), six
minute walk test(WT) and biochemical parameters namely,
serum albumin (S.Alb), calcium (S.Ca), phosphorous (S.Phos),
creatinine (S.Cr), 25 OH vitamin D (VITD) and parathyroid hor-
mone (PTH). Each individual were given injection cholecalciferol
600,000 IU and their EF, WT and biochemical parameters assessed
after two months. Statistical analysis was done by SPSS software.
Non parametric test were used for analysis (Wilcoxon signed
ranks test).
Results: The patient categorization: were 12 diabetics, 12 hyper-
tensives, 8 with IHD, 21 with NYHA class 2 and 9 with class 3,13
with Aspirin, 27 with ACI/ARB; 27 on loop diuretics, 28 on aldac-
tone, 27 on beta blockers. The baseline biochemical parameters
were S.Alb 3.5+0.43 g/dl; S.Cr 1.06+0.4 mg/dl; S.Ca 9+0.93 mg/dl;
S.Phos 3.5+0.37mg/dl; S.PTH 57+ 9 pg/ml; VITD 7.3 +1.5 ng/ml. Post
supplementation the VITD levels rose to 23+5.2 ng/ml (Z¼ -
4.703;P<0.0001). The baseline and post vitaminD supplementation
values were EF 28.77+5.5Vs 29.42+4.3% (Z¼ - 1.934;P<0.05); WT
296+98 Vs 308.6+96 (Z¼ - 1.675;P<0.09). The whole group was
analyzed after sub categorization NYHC and the type of therapy.
Walk test improved in patients without IHD WT 278+106 Vs
295+103(Z¼ - 2.173;P<0.03) and those without aspirin therapy WT
263+103.5 Vs 282+104 (Z¼ - 1.929;P<0.05).There was no significant
difference between NYHC 2 and 3; diabetics and non diabetics;
hypertension and non hypertensives; treatment with or without
ACI/ARB, loop diuretics, aldactone, beta blockers and digitalis
therapy.
Conclusions: Normalization 25 OH vitamin D levels with vitamin
D supplementation improved the EF and WT in patients without
IHD; without aspirin therapy in subjects with NYHA class 2and 3
failures. Studies with larger cohort in various categories will be
more informative.
Prognostic indicators of heart failure in Indian
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Medical University, Irkutsk, Russia
Background: Heart failure is a common cardiovascular disease
with high mortality and morbidity and its incidence is increasing.
In India it affects younger age group. Present study aims at iden-
tifying all patients with chronic heart failure in Indian population
over a period of two years at a tertiary care hospital. We aimed to
identify primary etiology of heart failure and delineate the
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prognostic indicators, so that aggressive management could be
initiated at the earliest.
Methods: It is a prospective descriptive study conducted in the
Kerala InstituteofMedical Sciences, over a 21monthperiod from1st
June 2012. 271 consecutive patients with NYHA class 3 or 4 with
various etiology of heart failure were identified. The patients
belonged to Valvular heart diseases, Cardiomyopathies, congenital
heart diseases, thyrotoxicosis, Cor pulmonale and hypervolemia
due to renal failure. Patientswithnewonsetmyocardial infarctions,
acute inflammatory conditions and septicemia were excluded.
Results: Of the 271 patients, 203 (75 %) were males and 68(25%)
were females. 184(67.99%) patients had systemic hypertension.
171(63.1%) patients had coronary artery disease. 28(10.3%) pa-
tients had dilated cardiomyopathy and 26 (9.59%) had valvular
heart disease. 21(7.7%) had chronic rheumatic heart disease.
Among them mitral valve disease was present in 16(6.27%) and
combination of mitral and aortic valve were 4(1.47%). 3 (1.1%)
patients had myxomatous disease of the mitral valve and only
2(0.73%) with degenerative aortic valve disease.18(6.6%) had
restrictive cardiomyopathy , 8(3.0%) had cor pulmonale with right
heart failure . 6( 2.2%) patients had congenital heart disease.
5(1.8%) patients had chemotherapy induced cardiomyopathy
(Doxorubicin and Adriamycin) . 4(1.5%) patients had primary
pulmonary hypertension , while 2(0.7%) patients has tachycardia
induced cardiomyopathy.
71(26.20%) had chronic kidney disease, 170(62.7%) were diabetic,
44(16.24%) were hypothyroid . 110(41.33%) patients were smokers
with ex smokers.
Sinus rhythm was present in 196 (72%) patients , 43 (16%) pa-
tients had atrial fibrillation, 20 (7%) had left bundle branch block, 4
(3%) had right bundle branch block and 8 ( 2%) with ventricular
tachycardia. Cerebro vascular accident was found in 28(10.5%)
patents ,in which 26 (9,5%) had emboli stroke and 2 (0.7%) had
hemorrhagic stroke. In patients with cerebro vascular accident ,
majority were coronary artery disease with severe left ventricular
dysfunction, dilated left ventricle (LV end diastolic diameter +_6.5
cm) and were in sinus rhythm 19(7%).
Average hospital stay was 7(+_4) days, maximum duration of
stay was 45 days, Prolonged stay was majority with heart failure
and renal failure. 10 (3.6%) patients required invasive ventilatory
support and 12(4.4) required non-invasive ventilatory support. 30
(11.2%) patients were readmitted within 30 days of discharge and
17( 7%) patients readmitted within 90days.
Mortality in this group of patients were 31 (11.5%) when we
followed up to 21months andmajority were in the age between 70
-79 (4.8%). Major cause of death 20(7.3%) was due to coronary ar-
tery disease. Death due to chronic rheumatic heart disease and
congenital heart disease were 3(1.1%), idiopathic dilated cardio-
myopathy and primary pulmonary hypertension were 2(6.4%) and
due to hypertrophic cardiomyopathy was 1(0.3%).
Conclusion: Heart failure is a multi-faceted syndrome with mul-
tiple etiologies. We found that systemic hypertension contributes
to heart failure 67.99% of patients and ischemic heart disease
contributes to 63.1% of patients. Diabetes was the commonest co
morbidity of heart failure in our study.
Echocardiographic profile of patient with diabetic
cardiomyopathy
M. Nagori, S. Gurmukhani, C. Vyas, S. Shah, T. Patel
Department of Cardiology, SMT NHLMMC, Ahmedabad, India
Background: Diabetic cardiomyopathy refers to a disease process
which affects the myocardium in diabetic patients causing a wide
range of structural abnormalities causing diastolic and systolic
dysfunction or a combination of these in the absence of coronary
artery disease and hypertension. In our study we tried to evaluate
echocardiographic profile of patient with diabetic cardiomyopa-
thy and its correlation with glycemic control.
Methods: In our study we evaluated 25 patient of diabetes with
clinical features of heart failure with normal epicardial coronaries
& without history of hypertension. We evaluated echocardio-
graphic feature and pattern of systolic and diastolic dysfunction &
its correlation with glycemic control in patient of diabetic
cardiomyopathy.
Results: In our study all 25 patient were having diastolic
dysfunction while systolic dysfunction was found in 5 patients.
Out of the patients with diastolic dysfunction, 7 patients were
having grade 1 diastolic dysfunction, 6 were having grade 2 dia-
stolic dysfunction, 9 having grade 3 diastolic dysfunction and 3
having grade 4 diastolic dysfunction. While out of 5 patient of
systolic dysfunction 3 were having severe systolic dysfunction EF
< 30% and 2were havingmoderate systolic dysfunction EF 30-45%.
Higher grades of systolic and diastolic dysfunction were asso-
ciated with poor glycemic control. Out of 25 patients, only 7 pa-
tients were having good glycemic control while 18 patients were
having poor glycemic control.
Conclusion: Most of the patients of diabetic cardiomyopathy have
diastolic dysfunction & higher grades of systolic and diastolic
dysfunction were associated with poor glycemic control.
To compare the safety and efficacy of
levosimendan and dobutamine inpatients with
acute decompensated heart failure
V.S.R. Bhupal, N. Lalitha, R.C. Barik, A. Shivaprasad, A. Suresh,
N. Rama, B. Srinivas, M. Jyotsna, A.N. Patnaik, D. Seshagiri Rao
Nizam's Institue of Medical Sciences, Hyderabad, India
Aim: The aim of this study is to compare the safety and efficacy of
levosimendan and dobutamine in patients with acute decom-
pensated heart failure.To compare the intensive care unit and
hospital stay between levosimendan and dobutamine groups.
Methods: A total of 30 consecutive patients hospitalized for acute
decompensated heart failure, LVEF30% were included in the
study. Patients were randomized 1:1 to either dobutamine (mini-
mum dose 5 mg kg-1 min-1) or levosimendan bolus (6mg kg-1) fol-
lowed by a infusion dose of levosimendan (0.1 mg kg-1min-1)for 48
hrs. Both treatment groups also received standard care.Effects on
haemodynamics were studied.The symptoms of dyspnea and fa-
tigue were evaluated by the patient and the physician at baseline
and after 48 hours.
Results: After 48 hrs increase in stroke volume [29% over baseline
for levosimendan compared with a 22% for dobutamine, p¼0.05]
and PCWP-lowering effect of levosimendan (28% decrease over
baseline for levosimendan compared with a 13% decrease for
dobutamine, p¼0.03) is significant. Intensive care unit stay in lev-
osimendan group is 1 day shorter than that of the standard treat-
ment group. Clinical symptoms of dyspnea and fatigue tended to
improvemorewith levosimendan than they didwith dobutamine.
Levosimendan group was associated with lesser arrhythmias.
Conclusions: Compared with dobutamine, a significantly higher
proportion of levosimendan patients experienced haemodynamic
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